Liver toxicity of rifampicin
Austerhoff, A.; Knop, P.; Brennecke, F.G.; Kindler, U.; Scholten, T.; Knieriem, H.J.
Die Medizinische Welt 24(17): 695-696
1973
ISSN/ISBN: 0025-8512 PMID: 4750930 Document Number: 69340
Document emailed within 1 workday
Related Documents
Rossolini, A.; Cellesi, C.; Debolini, A. 1973: Experimental study of liver damage due to rifampicin and rifampicin-isoniazid combination Il Farmaco; Edizione Pratica 28(6): 345-355Skakun, N.P.; Tabachuk, O.E. 1991: Comparative hepatic toxicity of isoniazid, rifampicin and ethambutol Problemy Tuberkuleza 1991(10): 77-79
Gort, A.; Falguera, M.; Schoenenberger, J.A. 1997: Rifampicin toxicity in HIV-infected patients: a study of its incidence and the risk factors Anales de Medicina Interna 14(11): 559-564
Kozma, D.; Tompa, A.; Schaff, Z.; Lapis, K. 1982: The effect of rifampicin and INH on the mouse liver Praxis und Klinik der Pneumologie 36(10): 429-433
Romero, A.; Grau, M.T.; Villamayor, F.; Sacristán, A.; Ortiz, J.A. 1997: Toxicity of ebrotidine on reproduction. Toxicity on fertility and general reproductive performance, embryo-fetal toxicity and peri- and postnatal toxicity Arzneimittel-Forschung 47(4a): 504-510
Kozma, D.; Mihalik, P. 1984: Liver and kidney damage in rifampicin and ethambutol treatment Zeitschrift für Erkrankungen der Atmungsorgane 162(3): 249-255
Wozniak, L.; Karasek, M.; Tomaszkiewicz, L.; Sosnowski, W. 1974: Toxic effect of rifampicin and ethambutol on liver in white mice Gruzlica i Choroby Pluc; Tuberculosis et Pneumonologia 42(9): 925-926
Medoff, G.; Kwan, C.N.; Schlessinger, D.; Kobayashi, G.S. 1973: Potentiation of rifampicin, rifampicin analogs, and tetracycline against animal cells by amphotericin B and polymyxin B Cancer Research 33(6): 1146-1149
Poupon, R.Y.; Meyniel, D.; Petit, J.; Gustot, P.; Darnis, F. 1979: Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin Annales de Medecine Interne 130(6-7): 371-375
Saltoglu, N.; Tasova, Y.; Inal, A.S.; Seki, T.; Aksu, H.S. 2002: Efficacy of rifampicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis Saudi Medical Journal 23(8): 921-924
Panchagnula, R.; Singh, I.; Kaur, K.J.; Kaul, C.L. 1999: Bioequivalence study of rifampicin in fixed-dose combination of rifampicin and isoniazid vs. separate formulations Methods and Findings in Experimental and Clinical Pharmacology 21(9): 625-628
Reimers, D. 1971: Malformations caused by rifampicin? 2 cases of normal fetal development after rifampicin treatment in early pregnancy Münchener Medizinische Wochenschrift 113(50): 1690-1691
Acocella, G.; Segre, G. 1974: Kinetics of rifampicin and desacetyl-rifampicin in plasma, bile, and urine in humans and the effect of repeated administrations Acta Pharmaceutica Suecica 11(6): 657-658
Westfal, I.; Zengteler, G.; Szymaczek-Meyer, L. 1974: Microscopic changes in liver in experimental tuberculosis in guinea pigs treated with rifampicin Gruzlica i Choroby Pluc; Tuberculosis et Pneumonologia 42(9): 879-885
Blanchon, P.; Paillas, J.; Groseille, Y.; Holler, A.; Blanchon, F. 1974: Classification of liver incidents occurring during antitubercular treatments which include rifampicin Annales de Medecine Interne 125(12): 919-922
Voigt, G. 1970: Liver toxicity of halothane Therapie der Gegenwart 109(6): 914-916
Watkins, P. 2000: COMT inhibitors and liver toxicity Neurology 55(11 Suppl 4: S51
Staerkel, P.; Horsmans, Y. 1999: Meloxicam-induced liver toxicity Acta Gastro-Enterologica Belgica 62(2): 255-256
Rozman, C.; Urbano, A.; Galera, H. 1971: Liver toxicity of anabolic steroids Münchener Medizinische Wochenschrift 113(25): 965-967
Gilroy, C.; Singh, A.; Chu, I.; Villeneuve, D.C. 1996: Toxicity of PCB 156 in the rat liver: an ultrastructural and biochemical study Journal of Submicroscopic Cytology and Pathology 28(1): 27-32